---
$id: https://graph.org.ai/products/commodity/51182432
$type: Product
source: UNSPSC
code: "51182432"
title: "Minodronic acid"
class: "51182400"
classTitle: "Calcium regulators and calcium salts"
family: "51180000"
familyTitle: "Hormones and hormone antagonists"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Minodronic acid

**UNSPSC Code**: 51182432
**Class**: [Calcium regulators and calcium salts](Calcium regulators and calcium salts.mdx)
**Family**: [Hormones and hormone antagonists](../Hormones and hormone antagonists.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a bone resorption inhibitor with the molecular formula C9H12N2O7P2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 40SGR63TGL, chemically known as 1-hydroxy-2-(imidazo(1,2-a)pyridin-3-yl)ethane-1,1-bisphosphonic acid monohydrate but generally known as minodronic acid, which bears US NIH Compound Identifier 130956. European Medicines Agency schedules Minodronic acid in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08981MIG. The term MINODRONIC ACID is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 12 No. 2 1999, List 40). Most nations schedule minodronic acid under HS 29339990 and SITC 51577. As of Q4 2014, MINODRONIC ACID remains the US FDA Preferred Term for this commodity. Minodronic acid bears US NLM identifiers UMLS ID C0256218 and NCI Concept Code C81673. SMILES: P(=O)(O)(O)C(P(=O)(O)O)(O)Cc1n2c(nc1)cccc2.

